Work

A phase II trial of BAY 43–9006 in metastatic melanoma with molecularly characterized B-Raf status

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.8046

Authors: E. Hardin, A. C. Pavlick, L. Liebes, I. Osman, A. Hamilton, J. Soon, D. Polsky, K. Friedman, J. Wright, F. Muggia

Institution: National Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2964870896

Cites:

Cited by: 2

Related to: 10